CAMILO JIMENEZ

TitleAssociate Professor
InstitutionMD Anderson
DepartmentEndocrine Neoplasia & HD
Address1400 Pressler St
Houston TX 77030-4008
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Casey RT, Hendriks E, Deal C, Waguespack SG, Wiegering V, Redlich A, Akker S, Prasad R, Fassnacht M, Clifton-Bligh R, Amar L, Bornstein S, Canu L, Charmandari E, Chrisoulidou A, Freixes MC, de Krijger R, de Sanctis L, Fojo A, Ghia AJ, Huebner A, Kosmoliaptsis V, Kuhlen M, Raffaelli M, Lussey-Lepoutre C, Marks SD, Nilubol N, Parasiliti-Caprino M, Timmers HHJLM, Zietlow AL, Robledo M, Gimenez-Roqueplo AP, Grossman AB, Ta?eb D, Maher ER, Lenders JWM, Eisenhofer G, Jimenez C, Pacak K, Pamporaki C. Author Correction: International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents. Nat Rev Endocrinol. 2024 Dec; 20(12):760. PMID: 39191988.
      Citations:    Fields:    
    2. Al Ward R, Waguespack SG, Varghese J, Lu Y, Jimenez C. Reply to the Letter to the Editor Concerning Metabolic and Pharma-cological Interactions of 131I-MIBG. Clin Nucl Med. 2024 Oct 10. PMID: 39388315.
      Citations:    Fields:    
    3. Szabo Yamashita T, Tame-Elorduy A, Skefos CM, Varghese JM, Habra MA, Fisher SB, Graham PH, Grubbs EG, Waguespack SG, Jimenez C, Perrier ND. SDHB-Associated Pheochromocytomas: What is Their Clinical Behavior? Ann Surg Oncol. 2024 Dec; 31(13):9007-9013. PMID: 39382746.
      Citations:    Fields:    
    4. Varghese J, Skefos CM, Jimenez C, Varghese J, Skefos CM, Jimenez C. Metastatic pheochromocytoma and paraganglioma: Integrating tumor biology in clinical practice. Mol Cell Endocrinol. 2024 Oct 01; 592:112344. PMID: 39182716.
      Citations:    Fields:    Translation:HumansAnimals
    5. Casey RT, Hendriks E, Deal C, Waguespack SG, Wiegering V, Redlich A, Akker S, Prasad R, Fassnacht M, Clifton-Bligh R, Amar L, Bornstein S, Canu L, Charmandari E, Chrisoulidou A, Freixes MC, de Krijger R, de Sanctis L, Fojo A, Ghia AJ, Huebner A, Kosmoliaptsis V, Kuhlen M, Raffaelli M, Lussey-Lepoutre C, Marks SD, Nilubol N, Parasiliti-Caprino M, Timmers HHJLM, Zietlow AL, Robledo M, Gimenez-Roqueplo AP, Grossman AB, Ta?eb D, Maher ER, Lenders JWM, Eisenhofer G, Jimenez C, Pacak K, Pamporaki C. International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents. Nat Rev Endocrinol. 2024 Dec; 20(12):729-748. PMID: 39147856.
      Citations:    Fields:    
    6. Sukrithan V, Perez K, Pandit-Taskar N, Jimenez C. Management of metastatic pheochromocytomas and paragangliomas: when and what. Curr Probl Cancer. 2024 Aug; 51:101116. PMID: 39024846.
      Citations:    Fields:    Translation:Humans
    7. Lagan? M, Balderrama-Brondani V, Herrera KR, Chahla B, Yaylaci F, Bassett RL, Jimenez C, Varghese J, Waguespack SG, Campbell MT, Shah AY, Rojas Hernandez CM, Habra MA. Venous thromboembolism in adrenocortical carcinoma: a retrospective analysis. Oncologist. 2024 Jul 05; 29(7):575-580. PMID: 38776552; PMCID: PMC11224981.
      Citations:    Fields:    Translation:Humans
    8. Lagan? M, Habra MA, Remde H, Almeida MQ, Cosentini D, Pusceddu S, Grana CM, Corssmit EPM, Bongiovanni A, De Filpo G, Lim ES, Zamparini M, Grisanti S, Deutschbein T, Fassnacht M, Fagundes GFC, Pereira MAA, Oldani S, Rota S, Prinzi N, Jimenez C, Berruti A, Almeida MQ, Fagundes GFC, Pereira MAA. Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma. Eur J Cancer. 2024 Sep; 208:114122. PMID: 39047533.
      Citations:    Fields:    Translation:Humans
    9. Al-Ward R, Brondani VB, Sawani S, Potter CL, Xu G, Waguespack SG, Varghese J, Habra MA, Lu Y, Jimenez C. High-Specific-Activity 131 I-MIBG for the Treatment of Advanced Pheochromocytoma and Paraganglioma. Clin Nucl Med. 2024 Jul 01; 49(7):610-620. PMID: 38630996.
      Citations:    Fields:    Translation:Humans
    10. Jimenez C, Habra MA, Campbell MT, Tamsen G, Cruz-Goldberg D, Long J, Bassett R, Dantzer R, Balderrama-Brondani V, Varghese J, Lu Y. Cabozantinib in patients with unresectable and progressive metastatic phaeochromocytoma or paraganglioma (the Natalie Trial): a single-arm, phase 2 trial. Lancet Oncol. 2024 May; 25(5):658-667. PMID: 38608693.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    11. Campbell MT, Balderrama-Brondani V, Jimenez C, Tamsen G, Marcal LP, Varghese J, Shah AY, Long JP, Zhang M, Ochieng J, Haymaker C, Habra MA. Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial. Lancet Oncol. 2024 May; 25(5):649-657. PMID: 38608694.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    12. Balderrama-Brondani V, Griffin AM, Owen TJ, Merriman KW, Chahla BB, Varghese J, Jimenez C, Waguespack SG, Graham PH, Perrier ND, Fisher SB, Karam JA, Shah AY, Campbell M, Hassan MM, Habra MA. Incidence and Geographical Distribution of Adrenocortical Carcinoma: Retrospective Analysis of a State Cancer Registry. Endocr Pract. 2024 Jan; 30(1):25-30. PMID: 37858722.
      Citations:    Fields:    Translation:Humans
    13. Jimenez C, Ma J, Roman Gonzalez A, Varghese J, Zhang M, Perrier N, Habra MA, Graham P, Waguespack SG. TNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma. J Clin Endocrinol Metab. 2023 04 13; 108(5):1132-1142. PMID: 36433823.
      Citations:    Fields:    Translation:Humans
    14. Toledo RA, Jimenez C, Armaiz-Pena G, Arenillas C, Capdevila J, Dahia PLM. Hypoxia-Inducible Factor 2 Alpha (HIF2a) Inhibitors: Targeting Genetically Driven Tumor Hypoxia. Endocr Rev. 2023 03 04; 44(2):312-322. PMID: 36301191; PMCID: PMC10216878.
      Citations: 7     Fields:    Translation:Humans
    15. Lu Y, Xu G, Jimenez C. Proposed MIBG Scan-Based Tumor Response Criteria of High-Specific-Activity 131 I-MIBG Therapy in Metastatic Pheochromocytoma/Paraganglioma. Clin Nucl Med. 2023 Apr 01; 48(4):320-323. PMID: 36758558.
      Citations:    Fields:    Translation:Humans
    16. Jimenez C, Lu Y. Functional Imaging Evidence of Tumor Response to High-Specific-Activity 131 I-MIBG Therapy in an 84-Year-Old Patient With Metastatic Pheochromocytoma/Paraganglioma. Clin Nucl Med. 2023 May 01; 48(5):426-427. PMID: 36728291.
      Citations:    Fields:    Translation:Humans
    17. Jimenez C, Chin BB, Noto RB, Dillon JS, Solnes L, Stambler N, DiPippo VA, Pryma DA. Biomarker response to high-specific-activity I-131 meta-iodobenzylguanidine in pheochromocytoma/paraganglioma. Endocr Relat Cancer. 2023 02 01; 30(2). PMID: 36472300; PMCID: PMC9874967.
      Citations:    Fields:    Translation:Humans
    18. Shirali AS, Clemente-Gutierrez U, Huang BL, Lui MS, Chiang YJ, Jimenez C, Fisher SB, Graham PH, Lee JE, Grubbs EG, Perrier ND. Pheochromocytoma recurrence in hereditary disease: does a cortical-sparing technique increase recurrence rate? Surgery. 2023 Jan; 173(1):26-34. PMID: 36229248.
      Citations:    Fields:    
    19. Yip L, Duh QY, Wachtel H, Jimenez C, Sturgeon C, Lee C, Vel?zquez-Fern?ndez D, Berber E, Hammer GD, Bancos I, Lee JA, Marko J, Morris-Wiseman LF, Hughes MS, Livhits MJ, Han MA, Smith PW, Wilhelm S, Asa SL, Fahey TJ, McKenzie TJ, Strong VE, Perrier ND. American Association of Endocrine Surgeons Guidelines for Adrenalectomy: Executive Summary. JAMA Surg. 2022 10 01; 157(10):870-877. PMID: 35976622; PMCID: PMC9386598.
      Citations:    
    20. Daher M, Varghese J, Gruschkus SK, Jimenez C, Waguespack SG, Bedrose S, Altameemi L, Bazerbashi H, Naing A, Subaiah V, Campbell MT, Shah AY, Zhang M, Sheth RA, Karam JA, Wood CG, Perrier ND, Graham PH, Lee JE, Habra MA. Temporal Trends in Outcomes in Patients With Adrenocortical Carcinoma: A Multidisciplinary Referral-center Experience. J Clin Endocrinol Metab. 2022 04 19; 107(5):1239-1246. PMID: 35092681; PMCID: PMC9016449.
      Citations:    Fields:    Translation:Humans
    21. Landry JP, Clemente-Gutierrez U, Pieterman CRC, Chiang YJ, Waguespack SG, Jimenez C, Habra MA, Halperin DM, Fisher SB, Graham PH, Perrier ND. Management of adrenocorticotropic hormone-secreting neuroendocrine tumors and the role of bilateral adrenalectomy in ectopic Cushing syndrome. Surgery. 2022 08; 172(2):559-566. PMID: 35437162; PMCID: PMC9681028.
      Citations:    Fields:    Translation:Humans
    22. Wu J, Lakomy DS, Fellman BM, Salcedo MP, Sood AK, Jhingran A, Klopp AH, Iyer RB, Jimenez C, Colbert LE, Eifel PJ, Schmeler KM, Lin LL. Longitudinal Changes in Bone Mineral Measurements Inside and Outside Radiation Fields Used for Cervical Cancer Treatment. Pract Radiat Oncol. 2022 Sep-Oct; 12(5):e423-e433. PMID: 35390531.
      Citations:    Fields:    
    23. Jimenez C, Xu G, Varghese J, Graham PH, Campbell MT, Lu Y. New Directions in Treatment of Metastatic or Advanced Pheochromocytomas and Sympathetic Paragangliomas: an American, Contemporary, Pragmatic Approach. Curr Oncol Rep. 2022 01; 24(1):89-98. PMID: 35061191.
      Citations:    Fields:    Translation:Humans
    24. Jimenez C, Armaiz-Pena G, Dahia PLM, Lu Y, Toledo RA, Varghese J, Habra MA. Endocrine and Neuroendocrine Tumors Special Issue-Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work? Cancers (Basel). 2022 Jan 18; 14(3). PMID: 35158739; PMCID: PMC8833823.
      Citations: 1     
    25. Liu Z, Ma J, Jimenez C, Zhang M. Pheochromocytoma: A Clinicopathologic and Molecular Study of 390 Cases From a Single Center. Am J Surg Pathol. 2021 09 01; 45(9):1155-1165. PMID: 34280940.
      Citations:    Fields:    Translation:Humans
    26. Pacak K, Akker SA, Aylwin SJB, Baudin E, Clifton-Bligh RJ, Dahia PLM, Grossman AB, Hicks RJ, Januszewicz A, Jimenez C, Kunst HPM, Lewis D, Mannelli M, Naruse M, Robledo M, Taylor DR, Timmers HJLM, Treglia G, Tufton N, Young WF, Lenders JWM, Amar L, Steichen O, Buffet A, Burnichon N, Fassnacht M, Herman P, Ta?eb D, Gimenez-Roqueplo AP, Lussey-Lepoutre C. International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers. Nat Rev Endocrinol. 2021 07; 17(7):435-444. PMID: 34021277; PMCID: PMC8205850.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    27. Jimenez C, Lopez-Montoya V, Gutierrez-Restrepo J, Grajales JLT, Aristizabal N, Pantoja D, Roman-Gonzalez A. Ectopic Cushing syndrome in Colombia. Arch Endocrinol Metab. 2021 May 18; 64(6):687-694. PMID: 34033277; PMCID: PMC10528621.
      Citations: 1     Fields:    Translation:Humans
    28. Fishbein L, Del Rivero J, Else T, Howe JR, Asa SL, Cohen DL, Dahia PLM, Fraker DL, Goodman KA, Hope TA, Kunz PL, Perez K, Perrier ND, Pryma DA, Ryder M, Sasson AR, Soulen MC, Jimenez C. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma. Pancreas. 2021 04 01; 50(4):469-493. PMID: 33939658.
      Citations: 8     Fields:    Translation:Humans
    29. Armaiz-Pena G, Flores SK, Cheng ZM, Zhang X, Esquivel E, Poullard N, Vaidyanathan A, Liu Q, Michalek J, Santillan-Gomez AA, Liss M, Ahmadi S, Katselnik D, Maldonado E, Salgado SA, Jimenez C, Fishbein L, Hamidi O, Else T, Lechan R, Tischler AS, Benn DE, Dwight T, Clifton-Bligh R, Vincent D, Aronin N, Biondi B, Koops M, Bowhay-Carnes E, Alvarez-Eslava A, Bruder JM, Kitano M, Ding Y, Dahia PLM, Sanso G, Barontini M, Gimenez-Roqueplo AP, Burnichon N. Genotype-Phenotype Features of Germline Variants of the TMEM127 Pheochromocytoma Susceptibility Gene: A 10-Year Update. J Clin Endocrinol Metab. 2021 01 01; 106(1):e350-e364. PMID: 33051659; PMCID: PMC7765648.
      Citations:    Fields:    Translation:Humans
    30. Economides MP, Shah AY, Jimenez C, Habra MA, Desai M, Campbell MT. A Durable Response With the Combination of Nivolumab and Cabozantinib in a Patient With Metastatic Paraganglioma: A Case Report and Review of the Current Literature. Front Endocrinol (Lausanne). 2020; 11:594264. PMID: 33329398; PMCID: PMC7731902.
      Citations: 1     Fields:    Translation:Humans
    31. Jimenez C, Subbiah V, Stephen B, Ma J, Milton D, Xu M, Zarifa A, Akhmedzhanov FO, Tsimberidou A, Habra MA, Rodon Anhert J, Fu S, Naing A. Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas. Cancers (Basel). 2020 Aug 16; 12(8). PMID: 32824391; PMCID: PMC7465458.
      Citations: 10     
    32. Dahia PLM, Clifton-Bligh R, Gimenez-Roqueplo AP, Robledo M, Jimenez C. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Metastatic pheochromocytomas and paragangliomas: proceedings of the MEN2019 workshop. Endocr Relat Cancer. 2020 08; 27(8):T41-T52. PMID: 32069214; PMCID: PMC7334096.
      Citations: 12     Fields:    Translation:Humans
    33. Jimenez C, Fazeli S, Rom?n-Gonzalez A. Antiangiogenic therapies for pheochromocytoma and paraganglioma. Endocr Relat Cancer. 2020 07; 27(7):R239-R254. PMID: 32369773.
      Citations: 9     Fields:    Translation:Humans
    34. Jimenez C, Wendt R, N??ez R. High-specific-activity iodine 131 metaiodobenzylguanidine for the treatment of metastatic pheochromocytoma or paraganglioma: a novel therapy for an orphan disease. Curr Opin Endocrinol Diabetes Obes. 2020 06; 27(3):162-169. PMID: 32250976.
      Citations: 3     Fields:    Translation:Humans
    35. Jimenez C, Habra MA, Kroiss M, Megerle F, Kurlbaum M, Zimmermann S, Wendler J, Lapa C, Quinkler M, Scherf-Clavel O, Fassnacht M. Objective Response and Prolonged Disease Control of Advanced Adrenocortical Carcinoma with Cabozantinib. J Clin Endocrinol Metab. 2020 05 01; 105(5). PMID: 31900481; PMCID: PMC8204945.
      Citations: 7     Fields:    Translation:Humans
    36. Jozaghi Y, Zafereo ME, Perrier ND, Wang JR, Grubbs E, Gross ND, Fisher S, Sturgis EM, Goepfert RP, Lai SY, Best C, Busaidy NL, Cabanillas ME, Dadu R, Gagel RF, Habra MA, Hu MI, Jimenez C, Sherman SI, Thosani S, Varghese J, Waguespack SG, Weitzman S, Ying AK, Graham PH. Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines. Head Neck. 2020 06; 42(6):1325-1328. PMID: 32437031; PMCID: PMC7262055.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    37. Salcedo MP, Sood AK, Jhingran A, Eifel PJ, Klopp AH, Iyer RB, Fellman BM, Jimenez C, Schmeler KM. Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women. Cancer. 2020 06 01; 126(11):2607-2613. PMID: 32125711; PMCID: PMC7220839.
      Citations: 3     Fields:    Translation:Humans
    38. Tritos NA, Mattsson AF, Vila G, Biller BMK, Klibanski A, Valluri S, Hey-Hadavi J, Kelepouris N, Jimenez C. All-cause mortality in patients with acromegaly treated with pegvisomant: an ACROSTUDY analysis. Eur J Endocrinol. 2020 Mar; 182(3):285-292. PMID: 31917681.
      Citations: 3     Fields:    Translation:Humans
    39. Naing A, Meric-Bernstam F, Stephen B, Karp DD, Hajjar J, Rodon Ahnert J, Piha-Paul SA, Colen RR, Jimenez C, Raghav KP, Ferrarotto R, Tu SM, Campbell M, Wang L, Sabir SH, Tapia C, Bernatchez C, Frumovitz M, Tannir N, Ravi V, Khan S, Painter JM, Abonofal A, Gong J, Alshawa A, McQuinn LM, Xu M, Ahmed S, Subbiah V, Hong DS, Pant S, Yap TA, Tsimberidou AM, Dumbrava EEI, Janku F, Fu S, Simon RM, Hess KR, Varadhachary GR, Habra MA. Phase 2 study of pembrolizumab in patients with advanced rare cancers. J Immunother Cancer. 2020 03; 8(1). PMID: 32188704; PMCID: PMC7078933.
      Citations: 32     Fields:    Translation:HumansCTClinical Trials
    40. Cabanillas ME, Ryder M, Jimenez C. Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond. Endocr Rev. 2019 12 01; 40(6):1573-1604. PMID: 31322645; PMCID: PMC7341904.
      Citations: 62     Fields:    Translation:HumansAnimals
    41. Jasim S, Jimenez C. Metastatic pheochromocytoma and paraganglioma: Management of endocrine manifestations, surgery and ablative procedures, and systemic therapies. Best Pract Res Clin Endocrinol Metab. 2020 03; 34(2):101354. PMID: 31685417.
      Citations: 5     Fields:    Translation:Humans
    42. Habra MA, Stephen B, Campbell M, Hess K, Tapia C, Xu M, Rodon Ahnert J, Jimenez C, Lee JE, Perrier ND, Boraddus RR, Pant S, Subbiah V, Hong DS, Zarifa A, Fu S, Karp DD, Meric-Bernstam F, Naing A. Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma. J Immunother Cancer. 2019 09 18; 7(1):253. PMID: 31533818; PMCID: PMC6751592.
      Citations: 32     Fields:    Translation:HumansCTClinical Trials
    43. Jimenez C, Erwin W, Chasen B. Targeted Radionuclide Therapy for Patients with Metastatic Pheochromocytoma and Paraganglioma: From Low-Specific-Activity to High-Specific-Activity Iodine-131 Metaiodobenzylguanidine. Cancers (Basel). 2019 Jul 20; 11(7). PMID: 31330766; PMCID: PMC6678905.
      Citations: 13     
    44. Kutahyalioglu M, Nguyen HT, Kwatampora L, Clarke C, Silva A, Ibrahim E, Waguespack SG, Cabanillas ME, Jimenez C, Hu MI, Sherman SI, Kopetz S, Broaddus R, Dadu R, Wanland K, Williams M, Zafereo M, Perrier N, Busaidy NL. Genetic profiling as a clinical tool in advanced parathyroid carcinoma. J Cancer Res Clin Oncol. 2019 Aug; 145(8):1977-1986. PMID: 31309300.
      Citations: 6     Fields:    Translation:Humans
    45. Habra MA, Sukkari MA, Hasan A, Albousen Y, Elsheshtawi MA, Jimenez C, Campbell M, Karam JA, Graham PH, Hatia RI, Phan AT, Varghese J, Hassan MM. Epidemiological risk factors for adrenocortical carcinoma: A hospital-based case-control study. Int J Cancer. 2020 04 01; 146(7):1836-1840. PMID: 31241762.
      Citations: 4     Fields:    Translation:Humans
    46. Waguespack SG, Machens A, Uchino S, Hasse-Lazar K, Else T, Dvorakova S, Qi XP, Elisei R, Glod J, Valdes N, Mathiesen J, Wohllk N, Bandgar TR, Drui D, Korbonits M, Druce MR, Brain C, Kurzawinski T, Fainstein-Day P, Klein M, Links TP, Letizia C, Fugazzola L, Canu L, Spehar Uroic A, Maiter D, Laboureau S, Mian C, Peczkowska M, Sebag F, Bausch B, Berdelou A, Sukurai A, Vlcek P, Krajewska J, Valerio L, Akshintala S, Godballe C, Jarzab B, Jimenez C, Eng C, Imai T, Schlumberger M, Grubbs E, Dralle H, Neumann HP, Baudin E, Castinetti F, Sanso G, Maia AL, Louren?o DM, Patocs A, Bugalho MJ, Lacroix A, Caron P, Borson Chazot F, Chabre O, Cohen R, Tabarin A, Brue T, Mirebeau-Prunier D, Leclerc L, Barontini M, Vaz Ferreira Vargas C, Ceolin L, Hoff A. Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study. Lancet Diabetes Endocrinol. 2019 03; 7(3):213-220. PMID: 30660595; PMCID: PMC8132299.
      Citations: 22     Fields:    Translation:Humans
    47. Sagiv O, Kandl TJ, Thakar SD, Thuro BA, Busaidy NL, Cabanillas M, Jimenez C, Dadu R, Graham PH, Debnam JM, Esmaeli B. Extraocular Muscle Enlargement and Thyroid Eye Disease-like Orbital Inflammation Associated with Immune Checkpoint Inhibitor Therapy in Cancer Patients. Ophthalmic Plast Reconstr Surg. 2019 Jan/Feb; 35(1):50-52. PMID: 29927883.
      Citations: 10     Fields:    Translation:Humans
    48. Pryma DA, Chin BB, Noto RB, Dillon JS, Perkins S, Solnes L, Kostakoglu L, Serafini AN, Pampaloni MH, Jensen J, Armor T, Lin T, White T, Stambler N, Apfel S, DiPippo VA, Mahmood S, Wong V, Jimenez C. Efficacy and Safety of High-Specific-Activity 131I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma. J Nucl Med. 2019 05; 60(5):623-630. PMID: 30291194; PMCID: PMC6495236.
      Citations: 56     Fields:    Translation:HumansCTClinical Trials
    49. Toledo R, Jimenez C. Recent advances in the management of malignant pheochromocytoma and paraganglioma: focus on tyrosine kinase and hypoxia-inducible factor inhibitors. F1000Res. 2018; 7. PMID: 30109021; PMCID: PMC6069727.
      Citations: 12     Fields:    Translation:HumansAnimals
    50. Zhou S, Ayala-Ramirez M, Shen C, Waguespack SG, Habra MA, Karam JA, Perrier N, Wood CG, Jimenez C, Roman-Gonzalez A. Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma. Ann Surg. 2018 07; 268(1):172-178. PMID: 28257320.
      Citations: 23     Fields:    Translation:Humans
    51. Jimenez C. Treatment for Patients With Malignant Pheochromocytomas and Paragangliomas: A Perspective From the Hallmarks of Cancer. Front Endocrinol (Lausanne). 2018; 9:277. PMID: 29892268; PMCID: PMC5985332.
      Citations: 23     Fields:    
    52. Romero Arenas MA, Rich TA, Hyde SM, Busaidy NL, Cote GJ, Hu MI, Gagel RF, Gidley PW, Jimenez C, Kupferman ME, Peterson SK, Sherman SI, Ying A, Bassett RL, Waguespack SG, Perrier ND, Grubbs EG. Recontacting Patients with Updated Genetic Testing Recommendations for Medullary Thyroid Carcinoma and Pheochromocytoma or Paraganglioma. Ann Surg Oncol. 2018 May; 25(5):1395-1402. PMID: 29427212; PMCID: PMC10013431.
      Citations: 6     Fields:    Translation:Humans
    53. Gallego S, Builes-Barrera CA, Castro DC, Jimenez C, Nore?a JA, Ni?o CD, Rom?n-Gonz?lez A. Calcitriol-mediated hypercalcemia secondary to granulomatous disease caused by soft-tissue filler injection: a case report. Clin Cases Miner Bone Metab. 2017 Sep-Dec; 14(3):340-346. PMID: 29354165; PMCID: PMC5762227.
      Citations: 2     
    54. Jimenez P, Tatsui C, Jessop A, Thosani S, Jimenez C. Treatment for Malignant Pheochromocytomas and Paragangliomas: 5?Years of Progress. Curr Oncol Rep. 2017 Oct 28; 19(12):83. PMID: 29081018.
      Citations: 21     Fields:    Translation:Humans
    55. Jasim S, Suman VJ, Jimenez C, Harris P, Sideras K, Burton JK, Worden FP, Auchus RJ, Bible KC. Phase II trial of pazopanib in advanced/progressive malignant pheochromocytoma and paraganglioma. Endocrine. 2017 Aug; 57(2):220-225. PMID: 28685225.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    56. Jimenez C, Roman-Gonzalez A. Malignant pheochromocytoma-paraganglioma: pathogenesis, TNM staging, and current clinical trials. Curr Opin Endocrinol Diabetes Obes. 2017 Jun; 24(3):174-183. PMID: 28234804.
      Citations: 30     Fields:    Translation:Humans
    57. Tritos NA, Jimenez C, King D, Klibanski A, Biller BM, Chanson P, J?nsson PJ. Effectiveness of first-line pegvisomant monotherapy in acromegaly: an ACROSTUDY analysis. Eur J Endocrinol. 2017 Feb; 176(2):213-220. PMID: 27932529.
      Citations: 6     Fields:    Translation:Humans
    58. Xu JY, Grubbs EG, Waguespack SG, Jimenez C, Gagel RF, Sosa JA, Sellin RV, Dadu R, Hu MI, Trotter CS, Jackson M, Rich TA, Hyde SM, Sherman SI, Cote GJ. Medullary Thyroid Carcinoma Associated with Germline RETK666N Mutation. Thyroid. 2016 12; 26(12):1744-1751. PMID: 27673361; PMCID: PMC5175438.
      Citations:    Fields:    Translation:Humans
    59. Xu JY, Murphy WA, Jimenez C, Rao SN, Habra MA, Waguespack SG, Dadu R, Gagel RF, Ying AK, Cabanillas ME, Weitzman SP, Busaidy NL, Sellin RV, Grubbs E, Sherman SI, Hu MI, Milton DR. Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma. J Clin Endocrinol Metab. 2016 12; 101(12):4871-4877. PMID: 27662441; PMCID: PMC5155685.
      Citations: 7     Fields:    Translation:Humans
    60. Xu JY, Handy B, Michaelis CL, Waguespack SG, Hu MI, Busaidy N, Jimenez C, Cabanillas ME, Fritsche HA, Cote GJ, Sherman SI. Detection and Prognostic Significance of Circulating Tumor Cells in Patients With Metastatic Thyroid Cancer. J Clin Endocrinol Metab. 2016 11; 101(11):4461-4467. PMID: 27575943; PMCID: PMC5095245.
      Citations: 11     Fields:    Translation:HumansCells
    61. Phan LM, Fuentes-Mattei E, Wu W, Velazquez-Torres G, Sircar K, Wood CG, Hai T, Jimenez C, Cote GJ, Ozsari L, Hofmann MC, Zheng S, Verhaak R, Pagliaro L, Cortez MA, Lee MH, Yeung SC, Habra MA. Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma. Cancer Res. 2015 Oct 01; 75(19):4131-42. PMID: 26282167; PMCID: PMC4592476.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    62. Ozsari L, Kutahyalioglu M, Elsayes KM, Vicens RA, Sircar K, Jazaerly T, Waguespack SG, Busaidy NL, Cabanillas ME, Dadu R, Hu MI, Vassilopoulou-Sellin R, Jimenez C, Lee JE, Habra MA. Preexisting adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosis. Endocrine. 2016 Feb; 51(2):351-9. PMID: 26206754.
      Citations: 8     Fields:    Translation:Humans
    63. Rich T, Jackson M, Shah K, Cote GJ, Jimenez C, Roman-Gonzalez A. Metastatic sympathetic paraganglioma in a patient with loss of the SDHC gene. Fam Cancer. 2015 Dec; 14(4):615-9. PMID: 26162468.
      Citations: 5     Fields:    Translation:Humans
    64. Jimenez C, Waguespack SG. Functional imaging for pheochromocytoma-paraganglioma: a step closer to understanding its place in clinical practice. Endocrine. 2015 Sep; 50(1):6-8. PMID: 26113425.
      Citations: 2     Fields:    Translation:Humans
    65. Thosani S, Ayala-Ramirez M, Zhou S, Thosani N, Bisanz A, Jimenez C, Rom?n-Gonz?lez A. Constipation: an overlooked, unmanaged symptom of patients with pheochromocytoma and sympathetic paraganglioma. Eur J Endocrinol. 2015 Sep; 173(3):377-87. PMID: 26060051.
      Citations: 17     Fields:    Translation:Humans
    66. Martucci VL, Emaminia A, del Rivero J, Lechan RM, Magoon BT, Galia A, Fojo T, Leung S, Lorusso R, Jimenez C, Shulkin BL, Audibert JL, Adams KT, Rosing DR, Vaidya A, Dluhy RG, Horvath KA, Pacak K. Succinate dehydrogenase gene mutations in cardiac paragangliomas. Am J Cardiol. 2015 Jun 15; 115(12):1753-9. PMID: 25896150; PMCID: PMC4450109.
      Citations: 11     Fields:    Translation:Humans
    67. Dadu R, Shah K, Busaidy NL, Waguespack SG, Habra MA, Ying AK, Hu MI, Bassett R, Jimenez C, Sherman SI, Cabanillas ME. Efficacy and tolerability of vemurafenib in patients with BRAF(V600E) -positive papillary thyroid cancer: M.D. Anderson Cancer Center off label experience. J Clin Endocrinol Metab. 2015 Jan; 100(1):E77-81. PMID: 25353071; PMCID: PMC4283003.
      Citations: 48     Fields:    Translation:Humans
    68. Cabanillas ME, Hu MI, Jimenez C. Medullary thyroid cancer in the era of tyrosine kinase inhibitors: to treat or not to treat--and with which drug--those are the questions. J Clin Endocrinol Metab. 2014 Dec; 99(12):4390-6. PMID: 25238206; PMCID: PMC4255127.
      Citations: 16     Fields:    Translation:Humans
    69. Shawa H, Elsayes KM, Javadi S, Sircar K, Jimenez C, Habra MA. Clinical and radiologic features of pheochromocytoma/ganglioneuroma composite tumors: a case series with comparative analysis. Endocr Pract. 2014 Sep; 20(9):864-9. PMID: 24641930.
      Citations: 8     Fields:    
    70. Rich TA, Feng L, Busaidy N, Cote GJ, Gagel RF, Hu M, Jimenez C, Lee JE, Perrier N, Sherman SI, Waguespack SG, Ying A, Grubbs E. Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations. Thyroid. 2014 Jul; 24(7):1096-106. PMID: 24617864; PMCID: PMC4080849.
      Citations: 13     Fields:    Translation:Humans
    71. Baudin E, Habra MA, Deschamps F, Cote G, Dumont F, Cabanillas M, Arfi-Roufe J, Berdelou A, Moon B, Al Ghuzlan A, Patel S, Leboulleux S, Jimenez C. Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma. Eur J Endocrinol. 2014 Sep; 171(3):R111-22. PMID: 24891137.
      Citations: 42     Fields:    Translation:HumansAnimals
    72. Hu MI, Ying AK, Jimenez C. Update on medullary thyroid cancer. Endocrinol Metab Clin North Am. 2014 Jun; 43(2):423-42. PMID: 24891170.
      Citations: 14     Fields:    Translation:Humans
    73. Dadu R, Waguespack SG, Sherman SI, Hu MI, Busaidy NL, Jimenez C, Habra MA, Ying AK, Bassett RL, Cabanillas ME. Efficacy and tolerability of different starting doses of sorafenib in patients with differentiated thyroid cancer. Oncologist. 2014 May; 19(5):477-82. PMID: 24733667; PMCID: PMC4012968.
      Citations: 12     Fields:    Translation:Humans
    74. Dadu R, Devine C, Hernandez M, Waguespack SG, Busaidy NL, Hu MI, Jimenez C, Habra MA, Sellin RV, Ying AK, Cote GJ, Sherman SI, Cabanillas ME. Role of salvage targeted therapy in differentiated thyroid cancer patients who failed first-line sorafenib. J Clin Endocrinol Metab. 2014 Jun; 99(6):2086-94. PMID: 24628550; PMCID: PMC4037722.
      Citations: 35     Fields:    Translation:Humans
    75. Abadin SS, Ayala-Ramirez M, Jimenez C, Dickson PV, Liang Y, Lazar AJ, Hornick JL, Cotton M, Sui D, Rich T, Lee JE, Grubbs E, Perrier ND. Impact of surgical resection for subdiaphragmatic paragangliomas. World J Surg. 2014 Mar; 38(3):733-41. PMID: 24390286.
      Citations: 1     Fields:    Translation:Humans
    76. Cabanillas ME, Hu MI, Jimenez C, Grubbs EG, Cote GJ. Treating medullary thyroid cancer in the age of targeted therapy. Int J Endocr Oncol. 2014; 1(2):203-216. PMID: 25908961; PMCID: PMC4405124.
      Citations: 6     
    77. Morris LF, Harris RS, Waguespack SG, Habra MA, Jimenez C, Vassilopoulou-Sellin R, Lee JE, Perrier ND, Grubbs EG, Milton DR. Impact and timing of bilateral adrenalectomy for refractory adrenocorticotropic hormone-dependent Cushing?s syndrome. Surgery. 2013 Dec; 154(6):1174-83; discussion 1183-4. PMID: 24383115; PMCID: PMC4271839.
      Citations: 12     Fields:    Translation:Humans
    78. Shawa H, Deniz F, Bazerbashi H, Hernandez M, Vassilopoulou-Sellin R, Jimenez C, Habra MA. Mitotane-induced hyperlipidemia: a retrospective cohort study. Int J Endocrinol. 2013; 2013:624962. PMID: 24348556; PMCID: PMC3848058.
      Citations: 5     
    79. Ayala-Ramirez M, Jasim S, Feng L, Ejaz S, Deniz F, Busaidy N, Waguespack SG, Naing A, Sircar K, Wood CG, Pagliaro L, Jimenez C, Vassilopoulou-Sellin R, Habra MA. Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center. Eur J Endocrinol. 2013 Dec; 169(6):891-899. PMID: 24086089; PMCID: PMC4441210.
      Citations: 90     Fields:    Translation:Humans
    80. Santarpia L, Calin GA, Adam L, Ye L, Fusco A, Giunti S, Thaller C, Paladini L, Zhang X, Jimenez C, Trimarchi F, El-Naggar AK, Gagel RF. A miRNA signature associated with human metastatic medullary thyroid carcinoma. Endocr Relat Cancer. 2013 Dec; 20(6):809-23. PMID: 24127332.
      Citations: 39     Fields:    Translation:HumansCells
    81. Shawa H, Elsayes KM, Javadi S, Morani A, Williams MD, Lee JE, Waguespack SG, Busaidy NL, Vassilopoulou-Sellin R, Jimenez C, Habra MA. Adrenal ganglioneuroma: features and outcomes of 27 cases at a referral cancer centre. Clin Endocrinol (Oxf). 2014 Mar; 80(3):342-7. PMID: 24033606.
      Citations: 22     Fields:    Translation:Humans
    82. Thosani S, Ayala-Ramirez M, Palmer L, Hu MI, Rich T, Gagel RF, Cote G, Waguespack SG, Habra MA, Jimenez C. The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2. J Clin Endocrinol Metab. 2013 Nov; 98(11):E1813-9. PMID: 24030942; PMCID: PMC5399523.
      Citations: 26     Fields:    Translation:Humans
    83. Jimenez C, Rohren E, Habra MA, Rich T, Jimenez P, Ayala-Ramirez M, Baudin E. Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma. Curr Oncol Rep. 2013 Aug; 15(4):356-71. PMID: 23674235.
      Citations: 64     Fields:    Translation:Humans
    84. Sridhara SK, Yener M, Hanna EY, Rich T, Jimenez C, Kupferman ME. Genetic testing in head and neck paraganglioma: who, what, and why? J Neurol Surg B Skull Base. 2013 Aug; 74(4):236-40. PMID: 24436918; PMCID: PMC3715610.
      Citations: 5     
    85. Ayala-Ramirez M, Palmer JL, Hofmann MC, de la Cruz M, Moon BS, Waguespack SG, Habra MA, Jimenez C. Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma. J Clin Endocrinol Metab. 2013 Apr; 98(4):1492-7. PMID: 23436918; PMCID: PMC5393459.
      Citations: 37     Fields:    Translation:Humans
    86. Grubbs EG, Rich TA, Ng C, Bhosale PR, Jimenez C, Evans DB, Lee JE, Perrier ND. Long-term outcomes of surgical treatment for hereditary pheochromocytoma. J Am Coll Surg. 2013 Feb; 216(2):280-9. PMID: 23317575.
      Citations: 17     Fields:    Translation:Humans
    87. Dickson PV, Alex GC, Grubbs EG, Jimenez C, Lee JE, Perrier ND. Robotic-assisted retroperitoneoscopic adrenalectomy: making a good procedure even better. Am Surg. 2013 Jan; 79(1):84-9. PMID: 23317617.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    88. Westin JR, Thompson MA, Cataldo VD, Fayad LE, Fowler N, Fanale MA, Neelapu S, Samaniego F, Romaguera J, Shah J, McLaughlin P, Pro B, Kwak LW, Sanjorjo P, Murphy WA, Jimenez C, Toth B, Dong W, Hagemeister FB. Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial. Clin Lymphoma Myeloma Leuk. 2013 Apr; 13(2):99-105. PMID: 23276888; PMCID: PMC3881262.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    89. Thosani N, Thosani SN, Kumar S, Nugent Z, Jimenez C, Singh H, Guha S. Reduced risk of colorectal cancer with use of oral bisphosphonates: a systematic review and meta-analysis. J Clin Oncol. 2013 Feb 10; 31(5):623-30. PMID: 23269990.
      Citations: 17     Fields:    Translation:Humans
    90. Carhill AA, Cabanillas ME, Jimenez C, Waguespack SG, Habra MA, Hu M, Ying A, Vassilopoulou-Sellin R, Gagel RF, Sherman SI, Busaidy NL. The noninvestigational use of tyrosine kinase inhibitors in thyroid cancer: establishing a standard for patient safety and monitoring. J Clin Endocrinol Metab. 2013 Jan; 98(1):31-42. PMID: 23185034; PMCID: PMC3537108.
      Citations: 30     Fields:    Translation:Humans
    91. Habra MA, Ejaz S, Feng L, Das P, Deniz F, Grubbs EG, Phan A, Waguespack SG, Ayala-Ramirez M, Jimenez C, Perrier ND, Lee JE, Vassilopoulou-Sellin R. A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma. J Clin Endocrinol Metab. 2013 Jan; 98(1):192-7. PMID: 23150683; PMCID: PMC3537094.
      Citations: 29     Fields:    Translation:Humans
    92. Ayala-Ramirez M, Chougnet CN, Habra MA, Palmer JL, Leboulleux S, Cabanillas ME, Caramella C, Anderson P, Al Ghuzlan A, Waguespack SG, Baudin E, Jimenez C, Deandreis D. Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas. J Clin Endocrinol Metab. 2012 Nov; 97(11):4040-50. PMID: 22965939; PMCID: PMC3683800.
      Citations: 64     Fields:    Translation:Humans
    93. Morris GS, Landry CL, Grubbs EG, Jimenez C, Busaidy NL, Perrier ND. Greater than age-predicted functional deficits in older patients with primary hyperparathyroidism. Endocr Pract. 2012 Jul-Aug; 18(4):450-5. PMID: 22784831.
      Citations: 4     Fields:    Translation:Humans
    94. Rianon N, Alex G, Callender G, Jimenez C, Hu M, Grubbs E, Moreno M, Wathoo C, Petak S, Perrier N. Preoperative serum osteocalcin may predict postoperative elevated parathyroid hormone in patients with primary hyperparathyroidism. World J Surg. 2012 Jun; 36(6):1320-6. PMID: 22278606.
      Citations: 3     Fields:    Translation:Humans
    95. Chuang HH, Deniz F, Sircar K, Jimenez C, Rubin De Celis C, Wood CG, Habra MA. [?8F]Fluorodeoxyglucose positron emission tomography-guided therapy in metastatic adrenocortical carcinoma: an illustrative case. J Clin Oncol. 2012 Sep 10; 30(26):e246-9. PMID: 22649135; PMCID: PMC3434990.
      Citations: 1     Fields:    Translation:Humans
    96. Fitzgerald P, Rich T, Ayala-Ramirez M, Perrier ND, Baudin E, Jimenez C, Plouin PF. Metastatic pheochromocytoma and paraganglioma: focus on therapeutics. Horm Metab Res. 2012 May; 44(5):390-9. PMID: 22314389.
      Citations: 35     Fields:    Translation:HumansAnimals
    97. Peck BW, Rich TA, Jimenez C, Kupferman ME. A novel SDHB mutation associated with hereditary head and neck paraganglioma. Laryngoscope. 2011 Dec; 121(12):2572-5. PMID: 22109755; PMCID: PMC3420815.
      Citations: 2     Fields:    Translation:Humans
    98. Ayala-Ramirez M, Feng L, Habra MA, Rich T, Dickson PV, Perrier N, Phan A, Waguespack S, Patel S, Jimenez C. Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience. Cancer. 2012 Jun 01; 118(11):2804-12. PMID: 22006217; PMCID: PMC3882190.
      Citations: 43     Fields:    Translation:Humans
    99. Khan MI, Habra MA, McCutcheon IE, Devin JK, Busaidy NL, Levine NB, Lindstrom W, Kagan D, Jimenez C, Waguespack SG, Nogueras-Gonz?lez GM. Random postoperative day-3 cortisol concentration as a predictor of hypothalamic-pituitary-adrenal axis integrity after transsphenoidal surgery. Endocr Pract. 2011 Sep-Oct; 17(5):717-26. PMID: 21454228.
      Citations: 1     Fields:    Translation:Humans
    100. Dickson PV, Alex GC, Grubbs EG, Ayala-Ramirez M, Jimenez C, Evans DB, Lee JE, Perrier ND. Posterior retroperitoneoscopic adrenalectomy is a safe and effective alternative to transabdominal laparoscopic adrenalectomy for pheochromocytoma. Surgery. 2011 Sep; 150(3):452-8. PMID: 21878230.
      Citations: 23     Fields:    Translation:Humans
    101. Thosani S, Jimenez C. Opioid-induced biochemical alterations of the neuroendocrine axis. Expert Rev Endocrinol Metab. 2011 Sep; 6(5):705-713. PMID: 30780884.
      Citations:    Fields:    
    102. Waguespack SG, Rich TA, Perrier ND, Jimenez C, Cote GJ. Management of medullary thyroid carcinoma and MEN2 syndromes in childhood. Nat Rev Endocrinol. 2011 Aug 23; 7(10):596-607. PMID: 21862994.
      Citations: 28     Fields:    Translation:Humans
    103. Varghese J, Ayala-Ramirez M, Rich T, Rohren E, Rao P, Jimenez C. Novel germline SDHD mutation: diagnosis and implications to the patient. Fam Cancer. 2011 Jun; 10(2):365-71. PMID: 21318381.
      Citations: 1     Fields:    Translation:Humans
    104. Varghese J, G?mez K, Jim?nez C. Medullary thyroid carcinoma: molecular signaling pathways and emerging therapies. J Thyroid Res. 2011; 2011:815826. PMID: 21687607; PMCID: PMC3112527.
      Citations: 9     
    105. Dickson PV, Jimenez C, Chisholm GB, Kennamer DL, Ng C, Grubbs EG, Evans DB, Lee JE, Perrier ND. Posterior retroperitoneoscopic adrenalectomy: a contemporary American experience. J Am Coll Surg. 2011 Apr; 212(4):659-65; discussion 665-7. PMID: 21463807.
      Citations: 11     Fields:    Translation:Humans
    106. Khan MI, Waguespack SG, Habra MA, Broaddus R, Jimenez C. Acute-onset ectopic adrenocorticotropic hormone syndrome secondary to metastatic endometrioid carcinoma of the ovaries as a fatal complication. J Clin Oncol. 2011 Jun 01; 29(16):e462-4. PMID: 21422435.
      Citations: 1     Fields:    Translation:Humans
    107. Ejaz S, Vassilopoulou-Sellin R, Busaidy NL, Hu MI, Waguespack SG, Jimenez C, Ying AK, Cabanillas M, Abbara M, Habra MA. Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience. Cancer. 2011 Oct 01; 117(19):4381-9. PMID: 21412758; PMCID: PMC3134535.
      Citations: 58     Fields:    Translation:HumansCTClinical Trials
    108. Varghese J, Rich T, Jimenez C. Benign familial hypocalciuric hypercalcemia. Endocr Pract. 2011 Mar-Apr; 17 Suppl 1:13-7. PMID: 21478088.
      Citations: 8     Fields:    Translation:Humans
    109. Ayala-Ramirez M, Feng L, Johnson MM, Ejaz S, Habra MA, Rich T, Busaidy N, Cote GJ, Perrier N, Phan A, Patel S, Waguespack S, Jimenez C. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin Endocrinol Metab. 2011 Mar; 96(3):717-25. PMID: 21190975.
      Citations: 138     Fields:    Translation:Humans
    110. Jasim S, Ying AK, Waguespack SG, Rich TA, Grubbs EG, Jimenez C, Hu MI, Cote G, Habra MA. Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation. Thyroid. 2011 Feb; 21(2):189-92. PMID: 21186952; PMCID: PMC3025175.
      Citations: 21     Fields:    Translation:Humans
    111. Jimenez C, Ayala-Ramirez M, Liu J, Nunez R, Gagel RF. Inhibition of growth hormone receptor activation by pegvisomant may increase bone density in acromegaly. Horm Metab Res. 2011 Jan; 43(1):55-61. PMID: 21104581.
      Citations: 4     Fields:    Translation:HumansCells
    112. Moskovic DJ, Smolarz JR, Stanley D, Jimenez C, Williams MD, Hanna EY, Kupferman ME. Malignant head and neck paragangliomas: is there an optimal treatment strategy? Head Neck Oncol. 2010 Sep 23; 2:23. PMID: 20863367; PMCID: PMC2956716.
      Citations: 9     Fields:    Translation:Humans
    113. Lodish MB, Adams KT, Huynh TT, Prodanov T, Ling A, Chen C, Shusterman S, Jimenez C, Merino M, Hughes M, Cradic KW, Milosevic D, Singh RJ, Stratakis CA, Pacak K. Succinate dehydrogenase gene mutations are strongly associated with paraganglioma of the organ of Zuckerkandl. Endocr Relat Cancer. 2010 Sep; 17(3):581-8. PMID: 20418362; PMCID: PMC3417306.
      Citations: 10     Fields:    Translation:Humans
    114. Morris GS, Grubbs EG, Hearon CM, Gantela S, Lee JE, Evans DB, Holmes HM, Busaidy NL, Jimenez C, Perrier ND. Parathyroidectomy improves functional capacity in "asymptomatic" older patients with primary hyperparathyroidism: a randomized control trial. Ann Surg. 2010 May; 251(5):832-7. PMID: 20395857.
      Citations: 3     Fields:    Translation:Humans
    115. Waguespack SG, Rich T, Grubbs E, Ying AK, Perrier ND, Ayala-Ramirez M, Jimenez C. A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2010 May; 95(5):2023-37. PMID: 20215394.
      Citations: 54     Fields:    Translation:Humans
    116. Ayala-Ramirez M, Callender GG, Kupferman ME, Rich TA, Chuang HH, Trent J, Perrier ND, Goodarzi M, Jimenez C. Paraganglioma syndrome type 1 in a patient with Carney-Stratakis syndrome. Nat Rev Endocrinol. 2010 Feb; 6(2):110-5. PMID: 20098451.
      Citations: 8     Fields:    Translation:Humans
    117. Habra MA, Chuang H, Ayala-Ramirez M, Rich T, Kyle K, Jimenez C, N??ez R. Fatal hypoglycemia in malignant pheochromocytoma: direct glucose consumption as suggested by (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography imaging. Endocrine. 2010 Feb; 37(1):209-12. PMID: 20963572.
      Citations: 6     Fields:    Translation:Humans
    118. Weaver S, Doherty DB, Jimenez C, Perrier ND. Peer-reviewed, evidence-based analysis of vitamin D and primary hyperparathyroidism. World J Surg. 2009 Nov; 33(11):2292-302. PMID: 19308641.
      Citations: 5     Fields:    Translation:Humans
    119. Perrier ND, Balachandran D, Wefel JS, Jimenez C, Busaidy N, Morris GS, Dong W, Jackson E, Weaver S, Gantela S, Evans DB, Grubbs EG, Lee JE. Prospective, randomized, controlled trial of parathyroidectomy versus observation in patients with "asymptomatic" primary hyperparathyroidism. Surgery. 2009 Dec; 146(6):1116-22. PMID: 19879613.
      Citations: 20     Fields:    Translation:Humans
    120. Stava CJ, Jimenez C, Hu MI, Vassilopoulou-Sellin R. Skeletal sequelae of cancer and cancer treatment. J Cancer Surviv. 2009 Jun; 3(2):75-88. PMID: 19412668.
      Citations: 20     Fields:    Translation:Humans
    121. Shin SH, Holmes H, Bao R, Jimenez C, Kee SS, Potylchansky E, Lee JE, Evans DB, Perrier ND. Outpatient minimally invasive parathyroidectomy is safe for elderly patients. J Am Coll Surg. 2009 Jun; 208(6):1071-6. PMID: 19476894.
      Citations: 7     Fields:    Translation:Humans
    122. Santarpia L, Habra MA, Jim?nez C. Malignant pheochromocytomas and paragangliomas: molecular signaling pathways and emerging therapies. Horm Metab Res. 2009 Sep; 41(9):680-6. PMID: 19343618.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    123. Perrier ND, Edeiken B, Nunez R, Gayed I, Jimenez C, Busaidy N, Potylchansky E, Kee S, Vu T. A novel nomenclature to classify parathyroid adenomas. World J Surg. 2009 Mar; 33(3):412-6. PMID: 19148701.
      Citations: 14     Fields:    Translation:Humans
    124. Jaishuen A, Jimenez C, Sirisabya N, Li Y, Zheng H, Hu W, Urbauer DL, Kavanagh JJ. Poor survival outcome with moderate and severe hypercalcemia in gynecologic malignancy patients. Int J Gynecol Cancer. 2009 Feb; 19(2):178-85. PMID: 19395991.
      Citations: 2     Fields:    Translation:Humans
    125. Grubbs EG, Rafeeq S, Jimenez C, Feng L, Lee JE, Evans DB, Perrier ND. Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial? Surgery. 2008 Dec; 144(6):852-8; discussion 858-9. PMID: 19040987.
      Citations: 14     Fields:    Translation:Humans
    126. Habra MA, Jimenez C, Huang SC, Cote GJ, Murphy WA, Gagel RF, Hoff AO. Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein as major factors involved in tumor-induced osteomalacia. Endocr Pract. 2008 Dec; 14(9):1108-14. PMID: 19158050.
      Citations: 10     Fields:    Translation:HumansCells
    127. Jimenez C, Cabanillas ME, Santarpia L, Jonasch E, Kyle KL, Lano EA, Matin SF, Nunez RF, Perrier ND, Phan A, Rich TA, Shah B, Williams MD, Waguespack SG. Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors. J Clin Endocrinol Metab. 2009 Feb; 94(2):386-91. PMID: 19017755.
      Citations: 42     Fields:    Translation:Humans
    128. Perrier ND, Kennamer DL, Bao R, Jimenez C, Grubbs EG, Lee JE, Evans DB. Posterior retroperitoneoscopic adrenalectomy: preferred technique for removal of benign tumors and isolated metastases. Ann Surg. 2008 Oct; 248(4):666-74. PMID: 18936580.
      Citations: 16     Fields:    Translation:Humans
    129. Jimenez C, Burman P, Abs R, Clemmons DR, Drake WM, Hutson KR, Messig M, Thorner MO, Trainer PJ, Gagel RF. Follow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trials. Eur J Endocrinol. 2008 Nov; 159(5):517-23. PMID: 18708436.
      Citations: 15     Fields:    Translation:Humans
    130. Rich TA, Jonasch E, Matin S, Waguespack SG, Gombos DS, Santarpia L, Stolle C, Jimenez C. A novel von Hippel-Lindau point mutation presents as apparently sporadic pheochromocytoma. Cancer Invest. 2008 Jul; 26(6):642-6. PMID: 18584357.
      Citations: 1     Fields:    Translation:HumansCells
    131. Hu MI, Gagel RF, Jim?nez C. Management of medullary thyroid carcinoma. Endocrinol Metab Clin North Am. 2008 Jun; 37(2):481-96, x-xi. PMID: 18502338.
      Citations: 27     Fields:    Translation:Humans
    132. Hu MI, Gagel RF, Jimenez C. Bone loss in patients with breast or prostate cancer. Curr Osteoporos Rep. 2007 Dec; 5(4):170-8. PMID: 18430392.
      Citations: 6     Fields:    Translation:Humans
    133. Stava CJ, Jimenez C, Vassilopoulou-Sellin R. Endocrine sequelae of cancer and cancer treatments. J Cancer Surviv. 2007 Dec; 1(4):261-74. PMID: 18648961.
      Citations: 9     Fields:    Translation:Humans
    134. Cote G, Arnold A, Gagel RF, Jim?nez C. Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes? J Clin Endocrinol Metab. 2006 Aug; 91(8):2851-8. PMID: 16735498.
      Citations: 33     Fields:    Translation:Humans
    135. Jimenez C, Yang Y, Kim HW, Al-Sagier F, Berry DA, El-Naggar AK, Patel S, Vassilopoulou-Sellin R, Gagel RF. Primary hyperparathyroidism and osteosarcoma: examination of a large cohort identifies three cases of fibroblastic osteosarcoma. J Bone Miner Res. 2005 Sep; 20(9):1562-8. PMID: 16059628.
      Citations: 7     Fields:    Translation:Humans
    136. Levis S, Gomez A, Jimenez C, Veras L, Ma F, Lai S, Hollis B, Roos BA. Vitamin d deficiency and seasonal variation in an adult South Florida population. J Clin Endocrinol Metab. 2005 Mar; 90(3):1557-62. PMID: 15634725.
      Citations: 70     Fields:    Translation:Humans
    137. Jimenez C, Moran SA, Sereti I, Wynne S, Yen PM, Falloon J, Davey RT, Sarlis NJ. Graves' disease after interleukin-2 therapy in a patient with human immunodeficiency virus infection. Thyroid. 2004 Dec; 14(12):1097-102. PMID: 15650365.
      Citations: 2     Fields:    Translation:HumansCells
    138. Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, Asper JA, Diaz EM, Evans DB, Gagel RF, Garden A, Hoff AO, Lee JE, Morrison WH, Rosenthal DI, Sherman SI, Sturgis EM, Waguespack SG, Weber RS, Wirfel K, Vassilopoulou-Sellin R. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004 Aug; 26(8):716-26. PMID: 15287039.
      Citations: 69     Fields:    Translation:Humans
    139. Jimenez C, Habra MA, Huang SC, El-Naggar A, Shapiro SE, Evans DB, Cote G, Gagel RF. Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation. J Clin Endocrinol Metab. 2004 Aug; 89(8):4142-5. PMID: 15292360.
      Citations: 4     Fields:    Translation:Humans
    140. Jimenez C, Dang GT, Schultz PN, El-Naggar A, Shapiro S, Barnes EA, Evans DB, Vassilopoulou-Sellin R, Gagel RF, Cote GJ, Hoff AO. A novel point mutation of the RET protooncogene involving the second intracellular tyrosine kinase domain in a family with medullary thyroid carcinoma. J Clin Endocrinol Metab. 2004 Jul; 89(7):3521-6. PMID: 15240641.
      Citations: 12     Fields:    Translation:HumansCells
    141. Jimenez C, Gagel RF. Genetic testing in endocrinology: lessons learned from experience with multiple endocrine neoplasia type 2 (MEN2). Growth Horm IGF Res. 2004 Jun; 14 Suppl A:S150-7. PMID: 15135800.
      Citations: 3     Fields:    Translation:HumansAnimals
    142. Genetic testing in head and neck paraganglioma. Journal of Neurological Surgery, Part B: Skull Base. 74:236-240.
    143. Detection and prognostic significance of circulating tumor cells in patients with metastatic thyroid cancer. Journal of Clinical Endocrinology and Metabolism. 101:4461-4467.
    144. Bone metastases and skeletal-related events in medullary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism. 101:4871-4877.
    145. Medullary Thyroid Carcinoma Associated with Germline RETK666N Mutation. Thyroid. 26:1744-1751.
    146. Pheochromocytoma in Urologic Practice. European Urology Focus. 1:231-240.
    147. Efficacy and tolerability of vemurafenib in patients with BRAFV600E positive papillary thyroid cancer. Journal of Clinical Endocrinology and Metabolism. 100:E77-E81.
    148. Hereditary Pheochromocytoma and Multiple Endocrine Neoplasia Type 2 (MEN2). 181-191.
    149. Mitotane-induced hyperlipidemia. International Journal of Endocrinology. 2013.
    150. Carcinoma neuroendocrino del intestino delgado. Revista Colombiana de Gastroenterologia. 23:77-82.
    151. Succinate Dehydrogenase Gene Mutations in Cardiac Paragangliomas. American Journal of Cardiology. 115:1753-1759.
    152. Insulinoma in a marathon runner illustrating the effects of exercise on insulin sensitivity and glucose homeostasis. Endocrinologist. 16:20-24.
    153. Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma. Cancer Research. 75:4131-4142.
    154. Opioid-induced biochemical alterations of the neuroendocrine axis. Expert Review of Endocrinology and Metabolism. 6:705-713.
    155. Preexisting adrenal masses in patients with adrenocortical carcinoma. Endocrine.
    156. Endocrinologic issues. 343-360.
    157. Clinical and radiologic features of pheochromocytoma/ganglioneuroma composite tumors. Endocrine Practice. 20:864-869.
    JIMENEZ's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (457)
    Explore
    _
    Co-Authors (123)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _